Markets
OptimizeRx Stock Plunges 7% In Monday Trading, Erasing $10 Million In Market Value
The healthcare marketing company's shares had fallen 13% over the previous month, and it lowered annual sales expectations Wednesday.
OptimizeRx (OPRX) news from Bullished: SEC filings, earnings, insider trades and deals, explained in plain English with links to the source documents.
Markets
The healthcare marketing company's shares had fallen 13% over the previous month, and it lowered annual sales expectations Wednesday.
SEC Filings
A major customer's spending has resumed, but cost cuts are doing more of the work in protecting profitability.
Earnings
Early contracting for 2027 is about 20% ahead, but management declined to set a growth floor for next year.